Markets By TradingView
9984
0

3 Great Stocks for Investors Seeking Low Risk - Abbott Laboratories

3 Great Stocks for Investors Seeking Low Risk - Abbott Laboratories ; 3 Great Stocks for Investors Seeking Low Risk - Abbott Laboratories

3 Great Stocks for Investors Seeking Low Risk - Abbott Laboratories
Yazar: Zack Smith

Yayınlanma: 1 Mart 2021 21:29

Güncellenme: 18 Kasım 2024 02:15

3 Great Stocks for Investors Seeking Low Risk - Abbott Laboratories

  While market valuations make some investors nervous, the number of those looking for lower-risk stocks is no small. No one really knows how the market will move in the next step, but investors can buy stocks of powerful businesses and be patient, avoiding risk in the long run. The longer an investor holds the shares, the more it overshadows the fluctuations in line with the quality of the business. We've compiled three high-quality stocks for investors who want growth but are concerned about the risk of decline. Shares of these companies can fall as the price of almost anything goes down in a market correction, but their failure to reward their shareholders by performing well in the long run is high because of their low risk business.

1- Abbott Laboratories

Healthcare stocks become defensive in times of economic downturn, which is because their businesses are in good condition. Abbott Laboratories (NYSE: ABT) is one of the most consistent growth stocks you will find in the industry. Provider of medical devices, pharmaceuticals and a wide variety of nutritional products to emerging market countries, the company has not been disappointed in its earnings for more than a decade. Abbott's fourth quarter results saw a huge increase in sales of COVID-19 test kits. Even if you cut $ 2.4 billion from coronavirus test kit sales, we are talking about the company that achieved a sales increase of 28 percent in the previous year. The slowdown in medical procedures around the world due to year-end fluctuations caused diagnostic and medical device sales to decline over the quarter. Abbott predicts that demand for COVID-19 testing has not yet reached its peak and demand will remain strong beyond 2021. Meanwhile, the recovery in routine medical procedures may cause the company to return to its remaining business. FreeStyle Libre glucose tracking system sales increased by more than 40 percent. Abbott expects earnings per share of $ 5.00 in 2021. Analysts thinks they will continue to increase their profits until 2023 and beyond after the pandemic. The company recently continued its 49-year series of dividend growth, increasing payments by 25 percent. This provided a 1.5 percent return, helping its investors to sleep well at night.   3 Great Stocks for Investors Seeking Low Risk - Abbott Laboratories Source: https://www.fool.com/

You may also be interested in:

US Consumer Spending Recovers

 
En Popüler Haberler

Yorum Yap

Yazılan yorumlar hiçbir şekilde Son Ekonomi Haberleri - Türkiye Dünya - ieconomy.io görüş ve düşüncelerini yansıtmamaktadır. Yorumlar, yazan kişiyi bağlayıcı niteliktedir.

Yorumlar

Henüz yorum yapan yok! İlk yorumu siz yapın...

Borsa, Kripto, Hisse, Emtia ve Döviz Haberleri

ieconomy: Türkiye'nin en kapsamlı ekonomi haber sitesi. Son dakika haberleri ve en güncel haberler ieconomy'da.